Great Lakes Advisors LLC Increases Position in Bath & Body Works, Inc. $BBWI

Key Points

• Great Lakes Advisors LLC increased its holdings in Bath & Body Works by 1,387.2% in Q1, accumulating 79,447 shares valued at approximately $2.4 million.
• Bath & Body Works recently declared a quarterly dividend of $0.20 per share, translating to an annualized yield of 2.8%.
• Analysts have positive outlooks for Bath & Body Works' stock, with a consensus rating of "Moderate Buy" and a target price averaging $41.62.

Great Lakes Advisors LLC grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 1,387.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,447 shares of the company's stock after purchasing an additional 74,105 shares during the quarter. Great Lakes Advisors LLC's holdings in Bath & Body Works were worth $2,409,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in BBWI. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Bath & Body Works by 38.9% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock valued at $1,265,000 after purchasing an additional 11,681 shares during the last quarter. Merit Financial Group LLC purchased a new stake in Bath & Body Works in the 1st quarter valued at $714,000. Nuveen Asset Management LLC increased its stake in shares of Bath & Body Works by 3.7% in the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after acquiring an additional 27,136 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Bath & Body Works by 3,642.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after acquiring an additional 1,606,988 shares during the period. Finally, Tremblant Capital Group purchased a new position in shares of Bath & Body Works during the 4th quarter worth $6,891,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Stock Performance

NYSE:BBWI opened at $28.15 on Thursday. The stock has a market capitalization of $5.81 billion, a P/E ratio of 8.35, a PEG ratio of 0.97 and a beta of 1.49. The company has a 50 day moving average price of $30.53 and a 200 day moving average price of $30.35. Bath & Body Works, Inc. has a fifty-two week low of $24.94 and a fifty-two week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same quarter in the previous year, the company earned $0.37 earnings per share. The firm's quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Research analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's dividend payout ratio (DPR) is 23.74%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. upped their price objective on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Barclays increased their price target on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a research note on Friday, August 29th. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the company an "overweight" rating in a research report on Thursday, May 15th. Wells Fargo & Company upped their price objective on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, May 14th. Finally, Telsey Advisory Group reissued an "outperform" rating and set a $38.00 target price on shares of Bath & Body Works in a research note on Thursday, August 28th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $41.62.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.